Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active specific immunotherapy for colorectal cancer.

Adrian A Indar1, Charles A Maxwell-Armstrong

  • 1Section of Surgery, University Hospital Nottingham, UK. Adrian.Indar@nottingham.ac.uk

Expert Review of Anticancer Therapy
|November 6, 2003
PubMed
Summary

Active specific immunotherapy, including vaccines and dendritic cell therapy, offers a potent approach to combat colorectal cancer by targeting tumor antigens. This review evaluates current clinical strategies for this advanced cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a telehealth monitoring service after colorectal surgery: A feasibility study.

World journal of gastrointestinal surgery·2017
Same author

Postoperative ileus: Recent developments in pathophysiology and management.

Clinical nutrition (Edinburgh, Scotland)·2015
Same author

Results of laparoscopic colorectal surgery from a national training center.

Asian journal of surgery·2013
Same author

Quantifying factors influencing operating theater teaching, participation, and learning opportunities for medical students in surgery.

Journal of surgical education·2013
Same author

Gender-related perceptions of careers in surgery among new medical graduates: results of a cross-sectional study.

American journal of surgery·2012
Same author

Recurrent gallstone ileus: time to change our surgery?

Journal of digestive diseases·2009

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Chemotherapy has limitations in treating metastatic and micrometastatic colorectal carcinomas.
  • Advances in molecular biology have identified tumor-associated antigens, enabling new therapeutic strategies.
  • Biological therapy has evolved into the era of immunotherapy for cancer treatment.

Purpose of the Study:

  • To review current immunotherapy strategies for colorectal cancer.
  • To emphasize the clinical aspects of these novel treatments.
  • To evaluate the efficacy of active specific immunotherapy against tumor-associated antigens.

Main Methods:

  • Review of current literature on immunotherapy for colorectal cancer.
  • Focus on active specific immunotherapy modalities.

Related Experiment Videos

  • Inclusion of tumor cell vaccines, anti-idiotypic antibody therapy, and dendritic cell vaccines.
  • Consideration of immunostimulatory cytokines for enhancing immune response.

    • Main Results:

    • Nonspecific immunotherapy has been largely replaced by active specific immunotherapy.
    • Targeting identifiable tumor-associated antigens elicits a potent and specific immune response.
    • Various active specific immunotherapy approaches are under investigation and development.
    • Clinical data on the efficacy and application of these strategies are being evaluated.

    Conclusions:

    • Active specific immunotherapy represents a significant advancement in colorectal cancer treatment.
    • Targeted immune responses against tumor antigens offer a promising alternative to traditional chemotherapy.
    • Further clinical evaluation is crucial to optimize immunotherapy strategies for colorectal cancer patients.